PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran. Electronic address: nahad.sedaghat@gmail.com.\', \'Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran.\', \'Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.\', \'Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(21)00683-010.1016/j.msard.2021.103417
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 34875487
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34875487>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34875487>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all